Martin Herrmann

机构：Friedrich-Alexander-Universität Erlangen-Nürnberg, Universität Ulm, Heidelberg University, Sichuan University, University Hospital Heidelberg, Universitätsklinikum Erlangen, West China Hospital of Sichuan University, University Medical Centre Mannheim · ORCID：0000-0002-0258-2484

发表论文 679 篇 · 总被引 40801 次 · h-index 97

代表论文

• Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality of life in patients with Post-COVID syndrome (reCOVer): a prospective, exploratory, placebo-controlled, double-blind, randomised phase IIa clinical trial (RCT) (2025 · EClinicalMedicine · 被引 12)
• A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis (2025 · Nature Communications · 被引 12)
• Neutrophils aggravate inflammatory lesions in intestinal organoids from necrotizing enterocolitis (2025 · Frontiers in Immunology · 被引 8)
• IgA displays site- and subclass-specific glycoform differences despite equal glycoenzyme expression (2025 · Cell Communication and Signaling · 被引 6)
• Colchicine inhibits monosodium urate crystal-mediated inflammation by influencing F-actin formation (2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 6)
• NET Formation Drives Tophaceous Gout (2025 · Gout Urate and Crystal Deposition Disease · 被引 2)